IGM Biosciences
Stock Forecast, Prediction & Price Target
IGM Biosciences (IGMS) stock Price Target by analysts
$18.75
Potential upside: 1364.84%
IGM Biosciences price prediction
What is IGM Biosciences stock analysts` prediction?
IGM Biosciences stock forecast: Based on 4 Wall Street analysts` predicted price targets for IGM Biosciences in the last 3 months, the avarage price target is $18.75, with a high forecast of $NaN. The average price target represents a 1364.84% change from the last price of $1.28.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
IGM Biosciences stock Price Target by analysts
Full breakdown of analysts given IGM Biosciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Etzer Darout BMO Capital | 0% 0/1 | 10 months ago | $21 1540.62% upside | $9.46 | StreetInsider | Previous targets (0) |
Stephen Willey Stifel Nicolaus | 0% 0/1 | 12 months ago | $25 1853.12% upside | $14.08 | StreetInsider | Previous targets (0) |
Brian Abrahams RBC Capital | 0% 0/2 | 12 months ago | $17 1228.12% upside | $16.54 | TheFly | Previous targets (1) |
Asthika Goonewardene Truist Financial | 0% 0/2 | 12 months ago | $12 837.5% upside | $16.54 | TheFly | Previous targets (1) |
Robert Driscoll Wedbush | 0% 0/1 | about 1 year ago | $25 1853.12% upside | $8.72 | TheFly | Previous targets (0) |
Michael Ulz Morgan Stanley | 0% 0/1 | about 1 year ago | $12 837.5% upside | $8.72 | StreetInsider | Previous targets (0) |
Brian Abrahams RBC Capital | 0% 0/2 | over 1 year ago | $20 1462.49% upside | $9.34 | StreetInsider | Previous targets (1) |
Unknown Truist Financial | N/A | about 3 years ago | $37 2790.62% upside | $19.53 | Benzinga | N/A |
Joel Beatty Robert W. Baird | 0% 0/1 | over 3 years ago | $31 2321.87% upside | $15.24 | Pulse 2.0 | Previous targets (0) |
Asthika Goonewardene Truist Financial | 0% 0/2 | over 3 years ago | $74 5681.25% upside | $25.85 | Benzinga | Previous targets (1) |
IGM Biosciences Financial Estimates
IGM Biosciences Revenue Estimates
IGM Biosciences EBITDA Estimates
IGM Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $1.06M 0% | $2.13M 99.25% | Avg: $10.42M Low: $1.60M High: $21.31M avg. 389.43% | Avg: $50.72M Low: $3.74M High: $71.40M avg. 386.54% | Avg: $273.95M Low: $20.23M High: $385.65M avg. 440.09% | Avg: $430.84M Low: $31.82M High: $606.52M avg. 57.27% |
Net Income
% change YoY
| $-160.68M N/A | $-214.24M -33.33% | $-246.41M -15.01% | Avg: $-231.62M Low: $-223.89M High: $-105.14M avg. 6.00% | Avg: $-236.74M Low: $-207.15M High: $-84.74M avg. -2.20% | Avg: $-51.53M Low: $-78.85M High: $10.51M avg. 78.23% | Avg: $18.04M Low: $-3.68M High: $27.61M avg. 135.02% |
EBITDA
% change YoY
| $-165.32M N/A | $-227.95M -37.88% | $-253.35M -11.14% | Avg: $2.08M Low: $321.75K High: $4.26M avg. 100.82% | Avg: $10.14M Low: $749.38K High: $14.28M avg. 386.54% | Avg: $54.79M Low: $4.04M High: $77.13M avg. 440.09% | Avg: $86.16M Low: $6.36M High: $121.30M avg. 57.27% |
EPS
% change YoY
| -$4.8 N/A | -$5.16 -7.50% | -$4.71 8.72% | Avg: -$3.24 Low: -$4.28 High: -$2.01 avg. 31.15% | Avg: -$2.85 Low: -$3.96 High: -$1.62 avg. 12.00% | Avg: -$0.99 Low: -$1.51 High: $0.2 avg. 65.47% | Avg: $0.35 Low: -$0.07 High: $0.53 avg. 135.02% |
Operating Expenses
% change YoY
| $165.32M N/A | $229.02M 38.53% | $265.59M 15.96% | Avg: $152.27M Low: $23.49M High: $311.36M avg. -42.66% | Avg: $740.89M Low: $54.73M High: $1.04B avg. 386.54% | Avg: $4.00B Low: $295.59M High: $5.63B avg. 440.09% | Avg: $6.29B Low: $464.88M High: $8.85B avg. 57.27% |
FAQ
What is IGM Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 54.26% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -223.89M, average is -231.62M and high is -105.14M.
What is IGM Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 318.33% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $1.60M, average is $10.42M and high is $21.31M.
What is IGM Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 60.91% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$4.28, average is -$3.24 and high is $-2.01.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering IGM Biosciences stock. The most successful analyst is Etzer Darout.